Australian public assessment report for ezetimibe and ...
There were no significant differences between rosuvastatin (5 or 10 mg) + ezetimibe 10 mg and rosuvastatin (10 or 20 mg) with respect to the percentage of patients with gastrointestinal (GI) related, allergic reactions or rash, and hepatitis related AEs, elevations in ALT or AST ≥ 3x ULN or CK elevations ≥ 10x ULN. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- tennessee public school report card
- texas public school report cards
- maryland public schools report card
- nyc public school report card
- oklahoma public schools report card
- public school report card template
- annual report for public company
- special education assessment report tem
- nist risk assessment report template
- psychological assessment report template
- apa psychological assessment report template
- nist security assessment report template